Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an ...
Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use ...
Researchers have developed software that enables 3D-printed objects to sense and respond to human movements. The system, ...
Summary] What this article aims to conveyIn business system development, there is a frequent tendency to easily delegate ...
Anthropic Guest Investigators program opens a 14-day application window for academic principal investigators to collaborate ...
Huawei's Ascend has been integrated into the code supporting DeepSeek's AI.Support is expanding beyond matrix calculations to ...